The global Corticosteroids API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Corticosteroids API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Corticosteroids API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Corticosteroids API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Corticosteroids API include Pfizer Inc, Sanofi Active Ingredient Solutions, TEVA, Hovione, Farmabios, Steroid SpA, Avik Pharmaceutical, Anuh Pharma and Symbiotec, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Corticosteroids API production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Corticosteroids API by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Corticosteroids API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Corticosteroids API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Corticosteroids API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Corticosteroids API sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Corticosteroids API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Corticosteroids API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer Inc, Sanofi Active Ingredient Solutions, TEVA, Hovione, Farmabios, Steroid SpA, Avik Pharmaceutical, Anuh Pharma and Symbiotec, etc.
By Company
Pfizer Inc
Sanofi Active Ingredient Solutions
TEVA
Hovione
Farmabios
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec
Wellona Pharma
Tianjin Tianyao Pharmaceutical
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Shanghai New Hualian Pharmaceutical
Zhejiang Hengdian Apeloa
Shandong Sito Bio-tech
Segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Triamcinolone
Methylprednisolone
Spironolactone
Other
Segment by Application
Asthma
Arthritis
Iupus
Allergies
Other
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Corticosteroids API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Corticosteroids API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Corticosteroids API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Corticosteroids API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Corticosteroids API Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Corticosteroids API 麻豆原创 Size by Type, 2018 VS 2022 VS 2029
1.2.2 Prednisone Series
1.2.3 Dexamethasone Series
1.2.4 Betamethasone Series
1.2.5 Triamcinolone
1.2.6 Methylprednisolone
1.2.7 Spironolactone
1.2.8 Other
1.3 麻豆原创 by Application
1.3.1 Global Corticosteroids API 麻豆原创 Size by Application, 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 Arthritis
1.3.4 Iupus
1.3.5 Allergies
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Corticosteroids API Production
2.1 Global Corticosteroids API Production Capacity (2018-2029)
2.2 Global Corticosteroids API Production by Region: 2018 VS 2022 VS 2029
2.3 Global Corticosteroids API Production by Region
2.3.1 Global Corticosteroids API Historic Production by Region (2018-2023)
2.3.2 Global Corticosteroids API Forecasted Production by Region (2024-2029)
2.3.3 Global Corticosteroids API Production 麻豆原创 Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Corticosteroids API Revenue Estimates and Forecasts 2018-2029
3.2 Global Corticosteroids API Revenue by Region
3.2.1 Global Corticosteroids API Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Corticosteroids API Revenue by Region (2018-2023)
3.2.3 Global Corticosteroids API Revenue by Region (2024-2029)
3.2.4 Global Corticosteroids API Revenue 麻豆原创 Share by Region (2018-2029)
3.3 Global Corticosteroids API Sales Estimates and Forecasts 2018-2029
3.4 Global Corticosteroids API Sales by Region
3.4.1 Global Corticosteroids API Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Corticosteroids API Sales by Region (2018-2023)
3.4.3 Global Corticosteroids API Sales by Region (2024-2029)
3.4.4 Global Corticosteroids API Sales 麻豆原创 Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Corticosteroids API Sales by Manufacturers
4.1.1 Global Corticosteroids API Sales by Manufacturers (2018-2023)
4.1.2 Global Corticosteroids API Sales 麻豆原创 Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Corticosteroids API in 2022
4.2 Global Corticosteroids API Revenue by Manufacturers
4.2.1 Global Corticosteroids API Revenue by Manufacturers (2018-2023)
4.2.2 Global Corticosteroids API Revenue 麻豆原创 Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Corticosteroids API Revenue in 2022
4.3 Global Corticosteroids API Sales Price by Manufacturers
4.4 Global Key Players of Corticosteroids API, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
4.5.2 Global Corticosteroids API 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Corticosteroids API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Corticosteroids API, Product Offered and Application
4.8 Global Key Manufacturers of Corticosteroids API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 麻豆原创 Size by Type
5.1 Global Corticosteroids API Sales by Type
5.1.1 Global Corticosteroids API Historical Sales by Type (2018-2023)
5.1.2 Global Corticosteroids API Forecasted Sales by Type (2024-2029)
5.1.3 Global Corticosteroids API Sales 麻豆原创 Share by Type (2018-2029)
5.2 Global Corticosteroids API Revenue by Type
5.2.1 Global Corticosteroids API Historical Revenue by Type (2018-2023)
5.2.2 Global Corticosteroids API Forecasted Revenue by Type (2024-2029)
5.2.3 Global Corticosteroids API Revenue 麻豆原创 Share by Type (2018-2029)
5.3 Global Corticosteroids API Price by Type
5.3.1 Global Corticosteroids API Price by Type (2018-2023)
5.3.2 Global Corticosteroids API Price Forecast by Type (2024-2029)
6 麻豆原创 Size by Application
6.1 Global Corticosteroids API Sales by Application
6.1.1 Global Corticosteroids API Historical Sales by Application (2018-2023)
6.1.2 Global Corticosteroids API Forecasted Sales by Application (2024-2029)
6.1.3 Global Corticosteroids API Sales 麻豆原创 Share by Application (2018-2029)
6.2 Global Corticosteroids API Revenue by Application
6.2.1 Global Corticosteroids API Historical Revenue by Application (2018-2023)
6.2.2 Global Corticosteroids API Forecasted Revenue by Application (2024-2029)
6.2.3 Global Corticosteroids API Revenue 麻豆原创 Share by Application (2018-2029)
6.3 Global Corticosteroids API Price by Application
6.3.1 Global Corticosteroids API Price by Application (2018-2023)
6.3.2 Global Corticosteroids API Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Corticosteroids API 麻豆原创 Size by Type
7.1.1 US & Canada Corticosteroids API Sales by Type (2018-2029)
7.1.2 US & Canada Corticosteroids API Revenue by Type (2018-2029)
7.2 US & Canada Corticosteroids API 麻豆原创 Size by Application
7.2.1 US & Canada Corticosteroids API Sales by Application (2018-2029)
7.2.2 US & Canada Corticosteroids API Revenue by Application (2018-2029)
7.3 US & Canada Corticosteroids API Sales by Country
7.3.1 US & Canada Corticosteroids API Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Corticosteroids API Sales by Country (2018-2029)
7.3.3 US & Canada Corticosteroids API Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Corticosteroids API 麻豆原创 Size by Type
8.1.1 Europe Corticosteroids API Sales by Type (2018-2029)
8.1.2 Europe Corticosteroids API Revenue by Type (2018-2029)
8.2 Europe Corticosteroids API 麻豆原创 Size by Application
8.2.1 Europe Corticosteroids API Sales by Application (2018-2029)
8.2.2 Europe Corticosteroids API Revenue by Application (2018-2029)
8.3 Europe Corticosteroids API Sales by Country
8.3.1 Europe Corticosteroids API Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Corticosteroids API Sales by Country (2018-2029)
8.3.3 Europe Corticosteroids API Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Corticosteroids API 麻豆原创 Size by Type
9.1.1 China Corticosteroids API Sales by Type (2018-2029)
9.1.2 China Corticosteroids API Revenue by Type (2018-2029)
9.2 China Corticosteroids API 麻豆原创 Size by Application
9.2.1 China Corticosteroids API Sales by Application (2018-2029)
9.2.2 China Corticosteroids API Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Corticosteroids API 麻豆原创 Size by Type
10.1.1 Asia Corticosteroids API Sales by Type (2018-2029)
10.1.2 Asia Corticosteroids API Revenue by Type (2018-2029)
10.2 Asia Corticosteroids API 麻豆原创 Size by Application
10.2.1 Asia Corticosteroids API Sales by Application (2018-2029)
10.2.2 Asia Corticosteroids API Revenue by Application (2018-2029)
10.3 Asia Corticosteroids API Sales by Region
10.3.1 Asia Corticosteroids API Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Corticosteroids API Revenue by Region (2018-2029)
10.3.3 Asia Corticosteroids API Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Corticosteroids API 麻豆原创 Size by Type
11.1.1 Middle East, Africa and Latin America Corticosteroids API Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Corticosteroids API Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Corticosteroids API 麻豆原创 Size by Application
11.2.1 Middle East, Africa and Latin America Corticosteroids API Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Corticosteroids API Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Corticosteroids API Sales by Country
11.3.1 Middle East, Africa and Latin America Corticosteroids API Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Corticosteroids API Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Corticosteroids API Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Pfizer Inc
12.1.1 Pfizer Inc Company Information
12.1.2 Pfizer Inc Overview
12.1.3 Pfizer Inc Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Pfizer Inc Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pfizer Inc Recent Developments
12.2 Sanofi Active Ingredient Solutions
12.2.1 Sanofi Active Ingredient Solutions Company Information
12.2.2 Sanofi Active Ingredient Solutions Overview
12.2.3 Sanofi Active Ingredient Solutions Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Sanofi Active Ingredient Solutions Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Sanofi Active Ingredient Solutions Recent Developments
12.3 TEVA
12.3.1 TEVA Company Information
12.3.2 TEVA Overview
12.3.3 TEVA Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 TEVA Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 TEVA Recent Developments
12.4 Hovione
12.4.1 Hovione Company Information
12.4.2 Hovione Overview
12.4.3 Hovione Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Hovione Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hovione Recent Developments
12.5 Farmabios
12.5.1 Farmabios Company Information
12.5.2 Farmabios Overview
12.5.3 Farmabios Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Farmabios Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Farmabios Recent Developments
12.6 Steroid SpA
12.6.1 Steroid SpA Company Information
12.6.2 Steroid SpA Overview
12.6.3 Steroid SpA Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Steroid SpA Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Steroid SpA Recent Developments
12.7 Avik Pharmaceutical
12.7.1 Avik Pharmaceutical Company Information
12.7.2 Avik Pharmaceutical Overview
12.7.3 Avik Pharmaceutical Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Avik Pharmaceutical Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Avik Pharmaceutical Recent Developments
12.8 Anuh Pharma
12.8.1 Anuh Pharma Company Information
12.8.2 Anuh Pharma Overview
12.8.3 Anuh Pharma Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Anuh Pharma Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Anuh Pharma Recent Developments
12.9 Symbiotec
12.9.1 Symbiotec Company Information
12.9.2 Symbiotec Overview
12.9.3 Symbiotec Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Symbiotec Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Symbiotec Recent Developments
12.10 Wellona Pharma
12.10.1 Wellona Pharma Company Information
12.10.2 Wellona Pharma Overview
12.10.3 Wellona Pharma Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Wellona Pharma Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Wellona Pharma Recent Developments
12.11 Tianjin Tianyao Pharmaceutical
12.11.1 Tianjin Tianyao Pharmaceutical Company Information
12.11.2 Tianjin Tianyao Pharmaceutical Overview
12.11.3 Tianjin Tianyao Pharmaceutical Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 Tianjin Tianyao Pharmaceutical Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Tianjin Tianyao Pharmaceutical Recent Developments
12.12 Zhejiang Xianju Pharmaceutical
12.12.1 Zhejiang Xianju Pharmaceutical Company Information
12.12.2 Zhejiang Xianju Pharmaceutical Overview
12.12.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 Zhejiang Xianju Pharmaceutical Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Zhejiang Xianju Pharmaceutical Recent Developments
12.13 Henan Lihua Pharmaceutical
12.13.1 Henan Lihua Pharmaceutical Company Information
12.13.2 Henan Lihua Pharmaceutical Overview
12.13.3 Henan Lihua Pharmaceutical Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.13.4 Henan Lihua Pharmaceutical Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Henan Lihua Pharmaceutical Recent Developments
12.14 Shanghai New Hualian Pharmaceutical
12.14.1 Shanghai New Hualian Pharmaceutical Company Information
12.14.2 Shanghai New Hualian Pharmaceutical Overview
12.14.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.14.4 Shanghai New Hualian Pharmaceutical Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Shanghai New Hualian Pharmaceutical Recent Developments
12.15 Zhejiang Hengdian Apeloa
12.15.1 Zhejiang Hengdian Apeloa Company Information
12.15.2 Zhejiang Hengdian Apeloa Overview
12.15.3 Zhejiang Hengdian Apeloa Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.15.4 Zhejiang Hengdian Apeloa Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Zhejiang Hengdian Apeloa Recent Developments
12.16 Shandong Sito Bio-tech
12.16.1 Shandong Sito Bio-tech Company Information
12.16.2 Shandong Sito Bio-tech Overview
12.16.3 Shandong Sito Bio-tech Corticosteroids API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.16.4 Shandong Sito Bio-tech Corticosteroids API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Shandong Sito Bio-tech Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Corticosteroids API Industry Chain Analysis
13.2 Corticosteroids API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Corticosteroids API Production Mode & Process
13.4 Corticosteroids API Sales and 麻豆原创ing
13.4.1 Corticosteroids API Sales Channels
13.4.2 Corticosteroids API Distributors
13.5 Corticosteroids API Customers
14 Corticosteroids API 麻豆原创 Dynamics
14.1 Corticosteroids API Industry Trends
14.2 Corticosteroids API 麻豆原创 Drivers
14.3 Corticosteroids API 麻豆原创 Challenges
14.4 Corticosteroids API 麻豆原创 Restraints
15 Key Finding in The Global Corticosteroids API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Pfizer Inc
Sanofi Active Ingredient Solutions
TEVA
Hovione
Farmabios
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec
Wellona Pharma
Tianjin Tianyao Pharmaceutical
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Shanghai New Hualian Pharmaceutical
Zhejiang Hengdian Apeloa
Shandong Sito Bio-tech
听
听
*If Applicable.
